A 10-Gene Signature Identified by Machine Learning for Predicting the Response to Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma

<div>Survival analysis of external validation cohort. (a) Violin plot demonstrating the expression level of 10 genes of interest in TACE responders and nonresponders. (b) OS of predicted response and nonresponse HCC patients receiving both adjuvant and postrecurrence TACE treatment. (c) OS of patients receiving adjuvant TACE treatment. (d) RFS of different group of patients receiving adjuvant TACE treatment. (e) OS of patients receiving postrecurrence TACE treatment. (f) OS of patients receiving liver resection only. (g) RFS of patients receiving liver resection only.</div>

Journal of Oncology

fig5

Figure 5

Figure 5: A 10-Gene Signature Identified by Machine Learning for Predicting the Response to Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma 

Figure 5 | A 10-Gene Signature Identified by Machine Learning for Predicting the Response to Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma 